What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study

OBJECTIVES: The objective of this study was to investigate the use of, and predictors for, pharmaceutical anticancer treatment (PACT) towards the end of a patient’s life in a country with a public healthcare system. DESIGN: Retrospective registry study. SETTING: Secondary care in Norway. PARTICIPANT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugge, Christoffer, Kaasa, Stein, Sæther, Erik Magnus, Melberg, Hans Olav, Sonbo Kristiansen, Ivar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477316/
https://www.ncbi.nlm.nih.gov/pubmed/34580099
http://dx.doi.org/10.1136/bmjopen-2021-050564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477316/
https://www.ncbi.nlm.nih.gov/pubmed/34580099
http://dx.doi.org/10.1136/bmjopen-2021-050564

Ejemplares similares